1ECMO Centre Karolinska, Department of Pediatric Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden.
2Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (http://journals.lww.com/ccmjournal).
Dr. Falk is a member of Extracorporeal Life Support Organization (ELSO, Ann Arbor, MI) Education group. Dr. Broman has received honoraria from Eurosets Srl, Medolla, Italy; Xenios, Heilbronn, Germany, for Medical Advisory Board consultancies; Maquet Getinge, Solna, Sweden; and Evolan Pharma, Danderyd, Sweden. He is a member of the independent research consortium European Extracorporeal Membrane Oxygenation (ECMO) Advisory Board, the EuroELSO Working Group for Innovation of Technology, the EuroELSO Scientific Committee, the ELSO Workgroup for Adult ECMO, and the ELSO Registry. Dr. Hultman has disclosed that he does not have any potential conflicts of interest.
For information regarding this article, E-mail: [email protected] sll.se